Jul 11, 2024 11:46AM
Oct 17, 2023 08:00AM
Sep 19, 2023 08:00AM
Sep 19, 2023 08:00AM
Sep 18, 2023 07:01AM
Sep 18, 2023 07:00AM
Sep 7, 2023 09:01AM Eloxx Pharmaceuticals (ELOX) Provides Program Updates on ELX-02 and ZKN-013
Sep 7, 2023 09:00AM
Aug 14, 2023 08:30AM
Jun 6, 2023 08:30AM
Jun 1, 2023 09:10AM
May 24, 2023 08:03AM
May 24, 2023 08:00AM
May 15, 2023 04:30PM Eloxx Pharmaceuticals Reports First Quarter 2023 Financial and Operating Results and Provides Business Update
May 2, 2023 08:04AM
May 2, 2023 08:00AM
May 2, 2023 08:00AM
Apr 3, 2023 08:00AM
Apr 3, 2023 08:00AM
Mar 28, 2023 04:45PM
Mar 28, 2023 04:45PM Eloxx Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application for ZKN-013
Mar 28, 2023 04:45PM
Feb 27, 2023 04:05PM
Feb 27, 2023 04:05PM
Jan 25, 2023 08:00AM
Jan 25, 2023 08:00AM
Dec 1, 2022 08:45AM
Dec 1, 2022 08:45AM Eloxx Pharmaceuticals Announces Reverse Stock Split Effective
Dec 1, 2022 08:45AM
Nov 10, 2022 05:15PM
Nov 10, 2022 05:15PM
Nov 1, 2022 04:30PM
Nov 1, 2022 04:30PM
Sep 14, 2022 04:07PM
Sep 14, 2022 04:05PM Eloxx Pharmaceuticals (ELOX) Reports Topline Results from Phase 2 Combination Clinical Trial of ELX-02
Sep 14, 2022 04:05PM
Sep 14, 2022 04:05PM
Aug 15, 2022 08:00AM
Aug 15, 2022 08:00AM
Jul 5, 2022 08:00AM
Jul 5, 2022 08:00AM
May 10, 2022 08:00AM Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
May 10, 2022 08:00AM
Mar 31, 2022 07:00AM
Mar 31, 2022 07:00AM
Mar 29, 2022 07:00AM
Mar 29, 2022 07:00AM
Nov 17, 2021 07:00AM
Nov 17, 2021 07:00AM Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2 Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients
Nov 17, 2021 07:00AM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All